药明康德大跌10.0%!中欧基金旗下1只基金持有
Sou Hu Cai Jing·2025-04-07 08:57

Core Viewpoint - WuXi AppTec's stock experienced a significant decline of 10.0% on April 7, indicating potential concerns among investors regarding the company's performance and market position [1]. Company Overview - WuXi AppTec, established in 2000, is located in Wuxi and primarily engages in research and development activities. The company has a registered capital of 29.53 billion RMB, with GE LI serving as the legal representative [1]. Shareholder Activity - Among WuXi AppTec's top shareholders is the China Europe Fund, which reduced its holdings in the company during the fourth quarter of the previous year. The fund has reported a year-to-date return of 4.45%, ranking 1657 out of 4592 in its category [1]. Fund Management - The fund manager of the China Europe Healthcare Mixed Fund is Ms. Ge Lan, who has a background in biomedical engineering from Northwestern University. She has held various research and fund management positions since joining China Europe Fund Management in October 2014 [4][5].